HLS Therapeutics, Inc. (HLS.TO)
4.50
0.00 (0.00%)
CAD |
TSX |
Feb 20, 16:00
HLS Therapeutics Profit Margin (Quarterly) : -29.00% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arch Biopartners, Inc. | -- |
| Biocure Technology, Inc. | -- |
| Resverlogix Corp. | -- |
| Microbix Biosystems, Inc. | -27.67% |
| Theratechnologies, Inc. | -25.17% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.50% |
| Return on Assets | -9.14% |
| Return on Invested Capital | -10.83% |
| Gross Profit Margin (Quarterly) | 40.43% |
| Operating Margin (Quarterly) | -10.17% |
| Return on Net Operating Assets | -10.43% |